This paper examines a longitudinal single-cell atlas that identifies the biological drivers behind the success or failure of BCMA-targeted CAR T cell therapy in multiple myeloma patients. The research highlights that long-term remission is not determined by cell dose, but rather by specific T cell phenotypes, particularly the presence of cytotoxic CD4+ T cells and memory-biased states. It also red...去小宇宙查看完整单集简介
前往小宇宙评论区与主播互动
前往小宇宙评论区与主播互动
Fler avsnitt av Paper Talk
Visa alla avsnitt av Paper TalkPaper Talk med 淼淼Elva finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
